Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
2002 1
2006 1
2008 7
2009 3
2010 3
2011 7
2012 5
2013 3
2014 2
2015 1
2016 1
2019 1
2020 3
2022 1
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Spinner CD, Gottlieb RL, Criner GJ, Arribas López JR, Cattelan AM, Soriano Viladomiu A, Ogbuagu O, Malhotra P, Mullane KM, Castagna A, Chai LYA, Roestenberg M, Tsang OTY, Bernasconi E, Le Turnier P, Chang SC, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wang H, Gaggar A, Brainard DM, McPhail MJ, Bhagani S, Ahn MY, Sanyal AJ, Huhn G, Marty FM; GS-US-540-5774 Investigators. Spinner CD, et al. Among authors: arribas lopez jr. JAMA. 2020 Sep 15;324(11):1048-1057. doi: 10.1001/jama.2020.16349. JAMA. 2020. PMID: 32821939 Free PMC article. Clinical Trial.
[The "induction-maintenance" strategy].
Arribas López JR. Arribas López JR. Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:8-11. doi: 10.1016/s0213-005x(08)76604-7. Enferm Infecc Microbiol Clin. 2008. PMID: 19572438 Review. Spanish.
[Consensus statement on the clinical management of human immunodeficiency virus-associated neurocognitive disorders].
Grupo de expertos del Grupo de Estudio de Sida (GeSIDA) y de la Secretaría del Plan Nacional sobre el Sida (SPNS); Podzamczer Palter D, Muñoz-Moreno JA, Alcolea Rodríguez D, Alonso Villaverde C, Antela López A, Blanch Andreu J, Casado Osorio JL, Galindo Puerto MJ, Garolera i Freixa M, Locutura Rupérez J, Lleó Bisa A, Prats París A, Pérez-Valero I, Portilla Sogorb J, Rovira Cañellas A, Téllez Molina MJ, Tiraboschi JM, Vergara Moragues E, Arribas López JR, Goenaga Sánchez MÁ, de León-Naranjo FL, Martínez Chamorro E, Polo Rodríguez R, Muñoz-Moreno JA, Podzamczer D. Grupo de expertos del Grupo de Estudio de Sida (GeSIDA) y de la Secretaría del Plan Nacional sobre el Sida (SPNS), et al. Among authors: arribas lopez jr. Enferm Infecc Microbiol Clin. 2014 Jan;32(1):37-47. doi: 10.1016/j.eimc.2013.03.005. Epub 2013 Apr 30. Enferm Infecc Microbiol Clin. 2014. PMID: 23642283 Spanish.
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.
Orkin C, Molina JM, Cahn P, Lombaard J, Supparatpinyo K, Kumar S, Campbell H, Wan H, Teal V, Jin Xu Z, Asante-Appiah E, Sklar P, Teppler H, Lahoulou R; DRIVE-FORWARD and DRIVE-AHEAD collaborators. Orkin C, et al. Lancet HIV. 2024 Feb;11(2):e75-e85. doi: 10.1016/S2352-3018(23)00258-8. Epub 2023 Dec 20. Lancet HIV. 2024. PMID: 38141637 Clinical Trial.
35 results